ProShare Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
+20,732
| New | +$1.01M | ﹤0.01% | 816 |
|
|
2024
Q4 | – | Sell |
-5,358
| Closed | -$252K | – | 2280 |
|
|
2024
Q3 | $252K | Sell |
5,358
-210
| -4% | -$9.87K | ﹤0.01% | 1581 |
|
|
2024
Q2 | $301K | Sell |
5,568
-223
| -4% | -$12K | ﹤0.01% | 1288 |
|
|
2024
Q1 | $395K | Buy |
5,791
+530
| +10% | +$36.1K | ﹤0.01% | 1239 |
|
|
2023
Q4 | $329K | Sell |
5,261
-62
| -1% | -$3.88K | ﹤0.01% | 1305 |
|
|
2023
Q3 | $242K | Buy |
5,323
+69
| +1% | +$3.13K | ﹤0.01% | 1345 |
|
|
2023
Q2 | $295K | Sell |
5,254
-556
| -10% | -$31.2K | ﹤0.01% | 1280 |
|
|
2023
Q1 | $263K | Sell |
5,810
-1,853
| -24% | -$83.8K | ﹤0.01% | 1282 |
|
|
2022
Q4 | $312K | Sell |
7,663
-141
| -2% | -$5.73K | ﹤0.01% | 1220 |
|
|
2022
Q3 | $510K | Buy |
7,804
+610
| +8% | +$39.9K | ﹤0.01% | 893 |
|
|
2022
Q2 | $437K | Sell |
7,194
-2,391
| -25% | -$145K | ﹤0.01% | 995 |
|
|
2022
Q1 | $602K | Sell |
9,585
-1,191
| -11% | -$74.8K | ﹤0.01% | 1167 |
|
|
2021
Q4 | $817K | Sell |
10,776
-5,502
| -34% | -$417K | ﹤0.01% | 1153 |
|
|
2021
Q3 | $1.82M | Buy |
16,278
+2,664
| +20% | +$298K | 0.01% | 734 |
|
|
2021
Q2 | $2.2M | Buy |
13,614
+3,194
| +31% | +$517K | 0.01% | 710 |
|
|
2021
Q1 | $1.27M | Sell |
10,420
-483
| -4% | -$58.9K | ﹤0.01% | 864 |
|
|
2020
Q4 | $1.67M | Sell |
10,903
-405
| -4% | -$62K | 0.01% | 691 |
|
|
2020
Q3 | $946K | Buy |
11,308
+1,557
| +16% | +$130K | ﹤0.01% | 737 |
|
|
2020
Q2 | $717K | Buy |
9,751
+1,556
| +19% | +$114K | ﹤0.01% | 801 |
|
|
2020
Q1 | $348K | Sell |
8,195
-4,661
| -36% | -$198K | ﹤0.01% | 832 |
|
|
2019
Q4 | $783K | Sell |
12,856
-1,941
| -13% | -$118K | ﹤0.01% | 885 |
|
|
2019
Q3 | $607K | Sell |
14,797
-645
| -4% | -$26.5K | ﹤0.01% | 913 |
|
|
2019
Q2 | $727K | Sell |
15,442
-2,318
| -13% | -$109K | ﹤0.01% | 880 |
|
|
2019
Q1 | $634K | Buy |
17,760
+95
| +0.5% | +$3.39K | ﹤0.01% | 938 |
|
|
2018
Q4 | $505K | Sell |
17,665
-1,739
| -9% | -$49.7K | ﹤0.01% | 946 |
|
|
2018
Q3 | $861K | Sell |
19,404
-426
| -2% | -$18.9K | 0.01% | 885 |
|
|
2018
Q2 | $1.17M | Sell |
19,830
-1,447
| -7% | -$85K | 0.01% | 776 |
|
|
2018
Q1 | $973K | Sell |
21,277
-823
| -4% | -$37.6K | 0.01% | 831 |
|
|
2017
Q4 | $519K | Buy |
+22,100
| New | +$519K | ﹤0.01% | 1113 |
|